ExLibris header image
SFX Logo
Title: EP4 as a Therapeutic Target for Aggressive Human Breast Cancer
Source:

International Journal of Molecular Sciences [1661-6596] Majumder, Mousumi yr:2018


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Li, X. "The EP4 antagonist, L-161,982, induces apoptosis, cell cycle arrest, and inhibits prostaglandin E2-induced proliferation in oral squamous carcinoma Tca8113 cells." Journal of Oral Pathology & Medicine 46.10 (2017): 991-997. Link to Full Text for this item Link to SFX for this item
2. Caselli, G. "Pharmacological characterisation of CR6086, a potent prostaglandin E2 receptor 4 antagonist, as a new potential disease-modifying anti-rheumatic drug." Arthritis Research & Therapy 20 (2018): 39-39. Link to Full Text for this item Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.